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Purpose: To determine whether proinflammatory cytokine genes were potential susceptibility candidate genes for Korean
patients with non-Sjogren dry eye, we investigated the association of the interleukin 1 beta (IL1B), interleukin 6 (IL6),
and interleukin 6 receptor (IL6R) variations with this disease in Korean patients.
Methods: Genomic DNA was extracted from blood samples of unrelated non-Sjogren dry eye patients and healthy control
individuals who visited the Eye Center and Health Promotion Center of St. Mary’s Hospital in Seoul, Korea. For screening
genetic variations in proinflammatory cytokine genes, the 511 (rs16944) and 31 (rs1143627) positions in the promoter
region of IL1B, rs1143634 in exon 5 of IL1B, rs1800795 of the IL6 promoter, and Asp358Ala (rs8192284) of IL6R were
genotyped using the polymerase chain reaction, restriction fragment length polymorphisms, and direct sequencing.
Results: Among the polymorphisms, rs1143634 (F105F) in exon 5 of IL1B was significantly different between the patient
and control groups. The frequency of the C/T genotype in dry eye patients was decreased relative to that of the control
subjects (10.4% versus 3.9%, p=0.043, OR=3.337). For the IL6R gene, the genotypic and allelic distribution of rs8192284
was different between the dry eye patients and the controls: CC genotype (p=0.017, OR=2.12) and C allele (OR=1.26).
Conclusions: This is the first report of genetic variation screening of proinflammatory cytokine genes in Korean non-
Sjogren dry eye patients. It is suggested that rs1143634 of IL1B and rs8192284 of IL6R act as susceptibility variations in
Korean non-Sjogren dry eye patients.
As defined by the International Dry Eye Workshop, dry
eye disease (DED) is a multifactorial disease of the tears and
ocular surface and results in symptoms of discomfort, visual
disturbance, and tear film instability, with potential damage
to the ocular surface. Two major etiological causes of DED is
aqueous tear-deficiency dry eye (ADDE) and evaporative dry
eye (EDE). And ADDE has two major subclasses, Sjogen dry
eye and non-Sjogren dry eye. non-Sjogren dry eye is a form
of ADDE due to lacrimal dysfunction, when the systemic
autoimmune features have been excluded [1].
DED  has  been  estimated  to  afflict  11%–22%  of  the
general  population,  depending  on  the  parameters  and
population studied [2]. Older women and urbanites seem to
be  more  affected  than  the  rest  of  the  population  [3,4].
Furthermore, systemic diseases such as arthritis and allergies
are  correlated  with  an  increased  incidence  of  DED  [4].
Numerous  conditions,  including  medications,  hormonal
changes, environment, and neural alterations are known to
cause non-Sjogren DED [5]. Recent studies have focused on
the  use  of  accurate  biologic  markers  and  diagnostic
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applications in establishing treatment strategies to cover the
multifactorial nature of non-Sjogren DED.
Although  the  exact  mechanism  of  non-Sjogren  DED
pathogenesis is not fully understood, hyperosmolarity and the
resultant inflammation are known to be key components [6].
Increased levels of proinflammatory cytokines and markers
have been observed in the tears and the ocular surface of non-
Sjogren  DED  patients.  Upregulation  of  inflammatory
cytokines, including interleukin-1α(IL1α and IL1β has been
observed  in  non-Sjogren  DED  [7,8].  In  addition,  various
experimental animal models have increased levels of tumor
necrosis  factor-α  (TNF-α),  matrix  metalloproteinase-9
(MMP-9), interleukin 6 (IL6), IL1α and IL1β [9-11]. The
ocular surface inflammation in non-Sjogren DED is sustained
by  an  ongoing  activation  and  infiltration  of  pathogenic
immune cells, primarily of the cluster of differentiation 4
(CD4+) T cell compartment [12-15]. The contribution of T
cells  to  the  immunopathogenesis  of  non-Sjogren  DED  is
supported  by  studies  that  have  shown  increased  T  cell
infiltration  of  the  conjunctiva  in  humans  and  animals
[16-19]. The author questioned whether the inflammation of
non-Sjogren DED is the cause or the consequences of the
pathogenesis  and  whether  the  genetic  susceptibility  have
some role in the occurrence of non-Sjogren DED.
In general, an immune-mediated inflammatory disease
(IMID) represents a group of various chronic conditions that
share  a  common  pathway  and  is  characterized  by  an
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2818unidentified  etiology.  However,  both  genetic  and
environmental  factors  play  an  important  role  in  its
pathogenesis  [20].  Recently,  genome-wide  association
(GWA) studies and genome-wide, non-synonymous single
nucleotide polymorphism (nsSNP) scans in humans have led
to the identification of several loci associated with disease
susceptibility. Each population holds a specific mutational
pool [21]. For these pools, most mutations have mild effects
individually  but  in  combination  with  other  alleles,  may
promote or inhibit occurrence of an IMID [22].
To  determine  whether  polymorphisms  altering  the
function or expression of proinflammatory cytokine genes
contribute  to  the  pathogenesis  of  non-Sjogren  DED,  we
screened the proinflammatory cytokine genes interleukin 1
beta (IL1B), IL6, and the IL6 receptor (IL6R) gene. To the best
of our knowledge, this study represents the first report of
genetic  variation  screening  for  proinflammatory  cytokine
genes associated with non-Sjogren DED.
METHODS
Study subjects and blood samples: The study sample included
251 patients with non-Sjoren DED and 109 healthy controls.
Written informed consent was obtained from all subjects, and
study was approved by the Medical Ethics Committee of the
Catholic University of Korea, Seoul, Korea. Blood samples
were collected after enrollment and were centrifuged at 405×
g for 15 min to obtain plasma that was then aliquoted and
stored at −70 °C until the day of analysis.
Data on DED: Eligible patients were at least 21 years of age
and had been diagnosed with DED. The inclusion criteria were
as follows: Schirmer test (without anesthesia) results of less
than 5 mm/5 min in at least 1 eye; low tear film breakup time
(<5 s); mild superficial punctate keratitis, defined as a corneal
punctuate fluorescein staining score of 1 or more in either eye
(scale,  0  [none]  to  3  [severe]);  and  symptoms  of  ocular
irritation as assessed by an Ocular Surface Disease Index score
[23] of 25 or more (on a scale of 0 through 59). The diagnosis
of  DED  was  based  on  the  assessment  of  the  signs  and
symptoms by 2 observers (K.N. and C.J.). Both examiners
analyzed  the  severity  levels  of  the  patients  after  taking
photographs of the anterior segments. The exclusion criteria
were as follows: an inflammatory disease not associated with
dry eye; ocular trauma or surgical history within the previous
year;  pregnancy;  systemic  diseases  such  as  diabetes  and
hypertension;  rheumatologic,  hematologic,  and  respiratory
diseases; systemic infection; and any other significant disease.
During the study, patients were excluded when they were
found  to  fulfill  any  of  the  above  exclusion  criteria,  even
though they may not have been aware of fulfilling any of these
criteria at the time of enrollment.
Healthy controls were selected from visitors who have
regular medical check-ups in the Health Promotion Center of
St. Mary’s Hospital in Seoul, Korea. Inclusion criteria were
as  follows:  No  subjective  ocular  symptoms;  no  abnormal
signs  of  the  eye  after  ophthalmic  examiner  of  the
ophthalmologist (K.N.); no ocular trauma or surgical history;
no systemic diseases confirmed by physician with their results
of medical examinations; and no medication history which
can affect the ocular surface physiology.
Genotyping: Genomic DNA was extracted from peripheral
blood samples using the QIAamp DNA blood kit (QIAGEN,
Valencia,  CA).  Polymerase  chain  reactions  (PCRs)  were
performed with 25 ng of genomic DNA as a template in a
mixture of PCR buffer, 2.5 mM MgCl2, 200 nM dNTPs, 0.4
pmol of each primer, and 0.75 units of h-Taq polymerase
(Solgent, Daejeon, Korea; Table 1). Bilateral polymorphism
in the proinflammatory cytokine gene cluster was determined
by PCR-restriction fragment length polymorphism (RFLP)
analysis  and  direct  sequencing.  For  screening  genetic
variations  in  proinflammatory  cytokine  genes,  the  −511
(rs16944) and 31 (rs1143627) positions in the promoter region
of IL1B, rs1143634 in exon 5 of IL1B, rs1800795 in the IL6
promoter,  and  Asp358Ala  (rs8192284)  in  IL6R  were
genotyped using PCR, RFLP analysis, and direct sequencing.
Statistical  analysis:  The  Hardy–Weinberg  equilibrium
(HWE)  was  calculated  using  the  GenePop  on  the  Web
(GENEPOP; for statistical analysis) web version 4.0 program.
To determine statistically significant differences in genotype
and allele frequencies between the two groups, we used the
χ2 test of Fisher’s exact test for the 2x2 contingency table file.
The descriptive statistics for observed differences in allele or
genotype distribution with the corresponding p value were
analyzed using the JavaStat (for odds ratio analysis ) web
software in combination with StatXact-8 software (Cytel Inc.,
Cambridge,  MA).  The  strength  of  the  association  was
estimated by odds ratio of risk (OR) and 95% confidence
intervals (CI). Haplotype frequencies and associations were
calculated  with  Haploview  (version  4.0)  that  ises  the
expectation maximization (EM) algorithm [23]. Haplotype
TABLE 1. POLYMORPHIC SITES OF IL1B, IL6, AND IL6R GENES.
Genes position dbSNPs Nucleotide Amino acids RFLP analysis
IL1B promoter rs16944 -511C>T   Aval RFLP
IL1B Exon 5 rs1143634 +3954C>T F105F TaqI RFLP
IL6 promoter rs1800795 -174G>C   NIaIII RFLP
IL6R Exon 9 rs8192284 c.1073A>C D358A HinfI RFLP
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basis  of  10,000  replications  to  obtain  the  empirical
significance  [24].  Values  of  p<0.05  were  considered
statistically significant.
RESULTS
The tested gene variations are as follows: rs16944 (−511T>C)
in  the  promoter  region  of  IL1B,  rs1143634  in  exon  5  of
IL1B, rs1800795 (−174G>C) in IL6, and rs8192284 (48865A)
in IL6R. The genotypic and allelic frequencies in IL1B, IL6,
and IL6R are listed in Table 1.
We found that rs1143634 (F105F) in exon 5 of IL1B was
significantly  different  from  Hardy–Weinberg  equilibrium
between DED patients and the controls. The frequency of the
CT genotype in DED patients was increased relative to that of
the control subjects (10.4% versus 3.9%, p=0.043, OR=3.337;
Figure  1).  The  rs16944  in  ILβ  showed  no  significant
differences in each groups. The genotype distribution of IL6
(rs1800795) did not show any significant deviation between
study and control groups.
For the IL6R gene, the genotypic and allelic distribution
of rs8192284 was different between the DED patients and the
controls: *C/*C genotype (p=0.017, OR=2.12) and *C allele
(OR=1.26; Figure 2).
DISCUSSION
The exact mechanism of DED has not been firmly established.
Desiccating environmental stress and changes in tear fluid
composition  accompanying  lacrimal  gland  dysfunction
appear to trigger ocular surface inflammation. Fundamental
to the health of the ocular surface is the immune system, which
is designed to respond rapidly to environmental and microbial
insults. However, sustained inflammation from this response
may result in the activation of the autoimmune system to self-
antigens  localized  to  the  ocular  surface  [25].  Aqueous-
deficient dry eye (ADDE) implies that dry eye is due to a
failure  of  lacrimal  galned  tear  secretion  and  has  2  major
groupings: Sjogren syndrome dry eye and non-Sjogren dry
eye [1]. Of the systemic autoimmune diseases that induce
lacrimal gland damage, Sjogren syndrome dry eye is likely
the best understood one. However, without results from blood
tests or other invasive tests, a clinician can have difficulty in
identifying whether a patient has Sjogren or non-Sjogren DED
since  both  diseases  have  similar  signs  and  symptoms.
Recently, the new concept has arisen that non-Sjogren DED
is  a  complex,  multifactorial  autoimmune  disorder  with  a
largely  unknown  pathogenesis.  The  conditions  associated
with non-Sjogren DED is primary lacrimal gland deficiency
including  age-related  dry  eye,  and  congenital  alacrima;
secondary lacrimal gland deficiency including sarcoidosis,
lymphoma, and AIDS; obstruction of the lacrimal ducts due
to trachoma, erythema multiforme, and chemical or thermal
burns; and reflex hyposecretion due to contact lens wear,
diabetes, 7th cranial nerve damage, and systemic drugs [1].
The presence of dysfunctional regulatory T cells (Tregs) and
the resistance of pathogenic T cells, especially Th17 cells, to
Treg suppression was demonstrated in a DED mouse model
[26].  Autoimmune  diseases,  including  IMID,  are  the
consequence of an inappropriate immune response directed to
Figure 1. The genotype polymorphism
of IL1β rs1143634 and IL1β rs16944.
A: The frequencies of *C/*T genotype
of IL1β rs1143634 in non-Sjogren dry
eye  patients  was  increased  compared
with the control subjects (10.4% versus
3.9%,  p=0.043,  OR=3.337).  B:  No
significant  differences  were  shown  in
the IL1β rs16944 polymorphism.
Figure 2. The genotype polymorphism
of IL6 rs1800795 and IL6R rs8192284.
A: No differences in frequencies with
rs1800795 in the IL6 gene. B: In the
IL6R  gene,  genotypic  and  allelic
distribution of rs8192284 was different
between non-Sjogren dry eye patients
and controls; *C/*C genotype (p=0.017,
OR=2.12) and *C allele (OR=1.26).
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2820self-antigens.  The  susceptibility  of  certain  individuals  to
developing an autoimmune disease is associated with multiple
genes, as well as other risk factors including environmental
triggers.  The  combined  role  of  genes,  environment,  and
immunity in the development of an autoimmune disease has
been the subject of interest for many investigators [27-30].
Most  studies  have  focused  on  the  downstream
components  of  DED  pathogenesis,  including  T  cells,
cytokines, and chemokines. However, little is known about
the genetic factors involved in the susceptibility to the disease.
We demonstrated that the genotypic and allelic distribution of
rs1143634  (F105F)  in  ILβ  and  rs8192284  in  IL6R  were
significantly different in DED patients compared to healthy
controls.
ILβ, a proinflammatory cytokine expressed by activated
macrophages and several other types of cells, is thought to
play  a  crucial  role  in  the  pathogenesis  of  autoimmune
diseases. IL1βwas initially known as one of the lymphocyte-
activating factors (LAFs), owing to its role in the induction of
T-cell proliferation and maturation [31,32]. Several reports
have  predicted  the  genetic  association  of  IL1β  with  the
development  of  Graves’  ophthalmopathy,  ankylosing
scleritis, and cystic fibrosis [33-35]. Our results demonstrated
that rs1143634 (F105F) in exon 5 of IL1β was significantly
different between patient and control groups. The frequencies
of the C/T genotypes were increased in the DED patients
relative to those of the control subjects. It has been reported
that  the  elevated  osmolarity  achieved  by  adding  sodium
chloride  to  the  culture  medium  of  corneal  epithelial  cells
increased the production of IL1β [36]. Using RNA isolated by
impression cytology from 15 patients with Sjogren DED, it
was  shown  that  ocular  surface  epitheliopathy,  squamous
metaplasia, and IL1β were highly correlated [37]. The exact
mechanism of the C/T genotype of rs1143634 (F105F) in exon
5 of IL1β is not confirmed; however, this phenotype may play
a role in the upregulation of IL1β.
We  also  observed  that  the  genotypic  and  allelic
distributions of rs8192284 in IL6R were different between
DED patients and controls: C/C genotype. A single nucleotide
polymorphism (rs8192284) has been described to result in an
amino acid substitution from aspartic acid to alanine (D358A)
[38].  This  change  has  an  effect  on  IL6R  shedding,  with
individuals carrying the minor C allele showing an increased
shedding of membrane-bound receptors than the non-C allele
carriers [39]. Plasma-soluble IL6R levels have been shown to
be  positively  associated  with  the  number  of  C  alleles  in
rheumatoid  arthritis  patients  [40].  IL6R  is  formed  by  2
different membrane glycoproteins: IL6Rα an 80-kDa type I
protein referred to as the ligand-binding subunit, and IL6Rβ
a  130-kDa  (gp130)  protein  referred  to  as  the  signal-
transducing subunit [41]. IL6 and IL6Rαform a low-affinity
complex that must bind with gp130 to form a high-affinity
complex that can transduce signals to the cytoplasm. The
exact  role  of  IL6  is  unclear,  and  both  its  pro-  and  anti-
inflammatory properties need to be shown in vivo and in vitro.
The previous studies hypothesized that the balance between
the pro- and anti-inflammatory effects of IL6 is tilted toward
the  proinflammatory  side  under  various  environmental
conditions in DED patients [41,42].
We are the first to report that rs1143634 (F105F) in exon
5 of IL1β and rs8192284 of IL6R were significantly associated
with non-Sjogren DED. Although the pathogenesis of non-
Sjogren DED is not clearly understood, our study has revealed
that there is a genetic susceptibility to disease occurrence. In
addition,  the  results  of  the  study  support  the  concept  of
autoimmunity in non-Sjogren DED. Future studies will need
to include more subjects and evaluate the corresponding levels
of  plasma  IL1βand  IL6R.  Moreover,  clinical  correlations
between these allelic variations and disease severity will need
to be examined.
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